Discover 3,507 paid clinical trials in Santa Monica, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,507
A Study of APG-3288 in Relapsed/Refractory Blood Cancers
for
Relapsed/Refractory Hematological Malignancies,
Location: Los Angeles CA, Grand Rapids MI, Jacksonville FL,
Sponsor: Ascentage Pharma Group Inc.
Sex: All
Age: 18+
Code: NCT07424833
Phase 1, Recruiting
New
Safety and Tolerability Evaluation of IgG Binding Protein LT
for
Safety and Tolerability in Healthy Volunteers
Location: Los Angeles CA
Sponsor: Bactolife A/S
Sex: All
Age: 18 - 70
Code: NCT07824011
Recruiting
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
for
Prostate Cancer, Prostate Adenocarcinoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: Male
Age: 18+
Code: NCT05751434
Phase 2, Recruiting
New
IgG Binding Protein LT in Support of a Healthy Gut on the Go
for
Gut Health, Gastrointestinal Symptoms, Safety in Healthy Adults
Location: Los Angeles CA
Sponsor: Bactolife A/S
Sex: All
Age: 18 - 70
Code: NCT07873957
Recruiting
New
A Study Evaluating TRIV-573 in Atopic Dermatitis
for
Atopic Dermatitis
Location: Los Angeles CA, Fountain Valley CA, Spokane WA, Calgary,
Sponsor: Triveni Bio
Sex: All
Age: 18 - 70+
Code: NCT07782333
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
New
An Open Label Pilot Study Assessing the Impact of Chromium Picolinate Supplementation on Appetite and Cravings in Overweight Individuals
for
Overweight (BMI > 25), Appetite, Craving
Location: Los Angeles CA
Sponsor: Nutrition 21, Inc.
Sex: All
Age: 35 - 70
Code: NCT07909109
Recruiting
Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)
for
Fragile X Syndrome
Location: Orange CA, Irvine CA, Sacramento CA, Phoenix AZ,
Sponsor: Mirum Pharmaceuticals, Inc.
Sex: Male
Age: 13 - 45
Code: NCT07209462
Phase 2, Recruiting
Topical Imiquimod Treatment of Oral Dysplasia
for
Oral Dysplasia, Leukoplakia Oral, Leukoplakia
Location: Los Angeles CA
Sponsor: University of Southern California
Sex: All
Age: 18+
Code: NCT07210775
Phase 1, Phase 2, Recruiting
A Research Study Exploring How Musculoskeletal Function and the Autonomic Nervous System Relate to Visceral Pain in Women With and Without Dysmenorrhea (Painful Periods).
EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND)
for
Single Gene NIPT
Location: Los Angeles CA, San Carlos CA, San Francisco CA,
Sponsor: Natera, Inc.
Sex: All
Age: 18+
Code: NCT06808880
Recruiting
A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
for
Extensive Stage Small Cell Lung Cancer
Location: Los Angeles CA, Seattle WA, Sioux Falls SD, St Louis MO,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07037758
Phase 1, Recruiting
Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS)
for
Relapsed/Refractory Multiple Myeloma (RRMM)
Location: Los Angeles CA, Reno NV, Tacoma WA, Lubbock TX,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07609940
Phase 4, Recruiting
Selinexor Treatment for Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy.
for
Refractory Multiple Myeloma
Location: West Hollywood CA
Sponsor: Oncotherapeutics
Sex: All
Age: 18+
Code: NCT04519476
Phase 1, Recruiting
A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery
for
Hemorrhage
Location: Torrance CA, Lakewood CO, St Louis MO, Chicago IL,
Sponsor: Corza Medical GmbH
Sex: All
Age: 0+
Code: NCT06664775
Phase 3, Recruiting
THC and CBD: A Controlled Human Study Probing a Harm Reduction Strategy
for
Abuse, Drug, Pain
Location: Los Angeles CA
Sponsor: University of California, Los Angeles
Sex: All
Age: 21 - 55
Code: NCT06859710
Phase 1, Recruiting
Digital Health Intervention for Self-Management and Telemonitoring in Chimeric Antigen Receptor (CAR-T) Therapy
for
Hematologic Malignancies
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07186192
Phase 3, Recruiting
A Dose-masked Study of Intravitreal Remigromig (EYE103) in Participants With NVAMD or Macular Edema Following BRVO